These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19572735)

  • 21. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIE Luminogen-Functionalized Hollow Mesoporous Silica Nanospheres for Drug Delivery and Cell Imaging.
    Fan Z; Li D; Yu X; Zhang Y; Cai Y; Jin J; Yu J
    Chemistry; 2016 Mar; 22(11):3681-5. PubMed ID: 26711307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulus-responsive nanomotors based on gated enzyme-powered Janus Au-mesoporous silica nanoparticles for enhanced cargo delivery.
    Llopis-Lorente A; García-Fernández A; Lucena-Sánchez E; Díez P; Sancenón F; Villalonga R; Wilson DA; Martínez-Máñez R
    Chem Commun (Camb); 2019 Oct; 55(87):13164-13167. PubMed ID: 31620732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A free-blockage controlled release system based on the hydrophobic/hydrophilic conversion of mesoporous silica nanopores.
    Wang W; Chen L; Xu LP; Du H; Wen Y; Song Y; Zhang X
    Chemistry; 2015 Feb; 21(6):2680-5. PubMed ID: 25504676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate.
    Strømme M; Brohede U; Atluri R; Garcia-Bennett AE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(1):140-148. PubMed ID: 20049785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Intracellular Controlled Drug Delivery and Tumor Therapy through in Situ Forming Ag Nanogates on Mesoporous Silica Nanocontainers.
    Liu C; Zheng J; Deng L; Ma C; Li J; Li Y; Yang S; Yang J; Wang J; Yang R
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11930-8. PubMed ID: 25966745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer.
    Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P
    Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time cell analysis of the cytotoxicity of a pH-responsive drug-delivery matrix based on mesoporous silica materials functionalized with ferrocenecarboxylic acid.
    Xu Z; Cai L; Jiang H; Wen Y; Peng L; Wu Y; Chen J
    Anal Chim Acta; 2019 Mar; 1051():138-146. PubMed ID: 30661610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic property measurement of surfactant-templated mesoporous silica films using time-resolved single-molecule imaging.
    Kennard R; DeSisto WJ; Giririjan TP; Mason MD
    J Chem Phys; 2008 Apr; 128(13):134710. PubMed ID: 18397097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.
    Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ
    Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
    de la Torre C; Mondragón L; Coll C; Sancenón F; Marcos MD; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M
    Chemistry; 2014 Nov; 20(47):15309-14. PubMed ID: 25303093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.